Pharmafile Logo
Pharmafocus logo
Advanced Search

Sales and Marketing

Showing 15 posts of 11527 posts found.

Shire gets FDA boost – but suffers trial setback

April 10, 2015 Research and Development, Sales and Marketing FDA, Shire, algs, lifitegrast, shp625

Shire has achieved mixed results in its attempts to get regulatory approval for two new treatments – bagging a priority …
News

RSA hires senior consultant

April 10, 2015 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Kris Richards, rsa

Life sciences executive search and interims specialist firm RSA has appointed a new senior consultant to its executive interims team. …
Appointment

Over one billion drugs dispensed in England in 2014, NHS report shows

April 9, 2015 Sales and Marketing HSCIC, NHS, drug cost, net ingredient cost, prescribing, prescription cost analysis, prescriptions

Patients in England collected over 1.1 billion prescription items in 2014, according to NHS figures. Statistics from the Health and …
News

Merck and Pfizer to co-promote cancer drug

April 9, 2015 Research and Development, Sales and Marketing Cancer, Merck, Merck KGaA, NSCLC, Pfizer, Xalkori, non-small cell lung cancer, oncology

Merck KgaA and Pfizer have agreed to co-promote the latter’s lung cancer treatment Xalkori, and form a new alliance that …
News

Cello Health Consulting gains senior marketer

April 8, 2015 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Cello, beverly hope, consulting, health

Healthcare strategic marketing consultancy Cello Health Consulting has appointed pharma marketer Beverly Hope as a senior consultant for its brand and portfolio …
Appointment

Gilead’s next-generation HIV drug to be FDA assessed

April 8, 2015 Research and Development, Sales and Marketing F/TAF, FDA, Gilead, HIV, Tenofovir Alafenamide, emtricitabine

Gilead Sciences has filed its second new drug application for a new combination HIV treatment with the FDA.The California-based company …
News

Amgen’s colorectal cancer drug EU approved

April 8, 2015 Sales and Marketing Amgen, Vectibix, ibrutinib, imbruvica, panitumumab, ristempa

The European Commission has shown Amgen’s cancer drug Vectibix the green light to treat patients in combination with chemotherapy for …
News

FDA to look again at Novo Nordisk insulin submissions

April 8, 2015 Research and Development, Sales and Marketing Novo Nordisk, Ryzodeg, Tresiba, diabetes, insulin degludec

Diabetes specialist firm Novo Nordisk has resubmitted its applications for two insulins to the FDA, along with new interim safety …
News

EU nod for Roche cancer drug and chemotherapy

April 8, 2015 Sales and Marketing Cancer, Roche, avastin, bevacizumab, cervical, chemotherapy, wet AMD

The European Commission has approved Roche’s Avastin in combination with standard chemotherapy for women with advanced cervical cancer.  Avastin (bevacizumab) …
News

Vaxon Biotech appoints founder as chief executive

April 8, 2015 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Konstantinos Kosmatopoulos, vaxon biotech

Paris-based Vaxon Biotech has announced its founder Dr Konstantinos Kosmatopoulos is moving from his current role as chief scientific officer …
Appointment

Takeda expands in the United Arab Emirates

April 7, 2015 Medical Communications, Sales and Marketing Dubai, NEMEA, Singapore, Takeda, UAE, United Arab Emirates, near east

Takeda has opened new UAE offices in Dubai amidst plans to expand its business in the Middle East. The Japanese …
News

Antibiotic resistance outbreak ‘could kill 80,000’, report warns

April 7, 2015 Research and Development, Sales and Marketing AMR, Nabriva Therapeutics, antibiotic resistance, bacteria, blood infections, infections

An antibiotic-resistant blood infection outbreak could lead to 80,000 deaths, according to a government report on threats to the UK. …
News

Hundreds of jobs threatened after big pharma deals close

April 7, 2015 Medical Communications, Research and Development, Sales and Marketing Deals, GSK, Jobs, Novartis, US, Valeant, job losses, redundancy, salix

Fresh from deals worth a combined $34 billion, GSK and Salix Pharmaceuticals have announced company restructures that have placed more …
News

Refining UK market access

April 7, 2015 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing NICE, UK, health, market access

“Some people have said NICE needs to change, it needs to create a new vision, but we say we need …
Feature

Shire plots new ADHD drug approval

April 7, 2015 Sales and Marketing ADHD, FDA, SHP465, Shire, Vyvanse, clinical trials, paediatrics

Shire is launching a new clinical trial as part of its FDA submission for a potential ADHD treatment. The company …
News
The Gateway to Local Adoption Series

Latest content

Scots neonatal innovations target hearing loss and earlier care

August 28, 2026

FDA grants De Novo authorisation to light-filtering device for migraine

August 28, 2026

Southgate opens Innovation Lab for logistics and fulfilment development

August 27, 2026

Bioptimus partners with Cancer Research Horizons to expand AI cancer data set

August 27, 2026

Agentis Health Group acquires Clinical Pharmacist Solutions

August 26, 2026